(Total Views: 544)
Posted On: 04/01/2020 7:19:51 AM
Post# of 155780
Sorry, I have to disagree.
Quote from the PR:
"
...)The new protocol for Severely Ill COVID-19 patients is for 342 patients, double blinded with 2:1 ratio. Patients enrolled in this trial are expected to be administered leronlimab for two weeks with the primary endpoint being the mortality rate at 14 days.(...)"
We are living in a cruel world, so some lifes will be sacrificed.
Quote from the PR:
"
...)The new protocol for Severely Ill COVID-19 patients is for 342 patients, double blinded with 2:1 ratio. Patients enrolled in this trial are expected to be administered leronlimab for two weeks with the primary endpoint being the mortality rate at 14 days.(...)" We are living in a cruel world, so some lifes will be sacrificed.
(2)
(0)
